PROM1 and ovarian cancer: Expression of both of these markers at both the mRNA and protein level as well as the proportion of CD133+ve and ALDHhigh cells detected by flow cytometry is increased in response to the growth of glioblastoma and ovarian cancer cell lines in 1% oxygen (18–20).